Summary
Overview
Work History
Education
Skills
Websites
Publications
Timeline
Generic

ERIN K. MANGAN PHD

Ocean View,DE

Summary

Visionary and innovative Medical Affairs executive leader with a proven track record of driving change and recruiting top talent. Recognized for building high-performing medical teams. Multidisciplinary experience in Immunology, Rheumatology, Dermatology, Biosimilars, Inflammation, Gastroenterology, Neuroscience, Pain, Urology, and Women's Health. Expertise in developing global and US medical strategies through collaboration with external experts, medical societies, and patient advocacy groups. Successfully translated new knowledge into clinical development opportunities and launched multiple products in specialty care and internal medicine within tight timeframes. Strong acumen in designing pivotal clinical trials (phase IIIb/IV) and extensive experience in external medical communication platforms. Notable publications in prestigious scientific journals in both medical affairs and clinical development. Honored with over 50 awards for exceptional work as an individual and team leader. Knowledgeable Executive Leader with proven track record of leading organizations to growth and success through strategic planning and innovative problem-solving. Successfully managed diverse teams, driving operational efficiency, and fostering collaborative environments. Demonstrated excellence in financial oversight and stakeholder engagement. Developed leadership and strategic planning skills in fast-paced, high-stakes environment, ready to transition to new field. Expertise in financial oversight and team coordination ensures efficient operations and strong organizational growth. Looking to leverage these skills in new and challenging role. Knowledgeable Executive Leader with proven track record of leading organizations to growth and success through strategic planning and innovative problem-solving. Successfully managed diverse teams, driving operational efficiency, and fostering collaborative environments. Demonstrated excellence in financial oversight and stakeholder engagement. Versatile Executive Director focused on promoting mission and increasing effectiveness of key programs. Passionate about managing and overseeing implementation of company's daily operations. Quick and firm decision-maker possessing first-rate communication and organizational skills. Recognized for successfully collaborating with management to develop work plans, financials and strategies.

Overview

16
16
years of professional experience

Work History

Executive Director and Therapeutic Area Lead

BOEHRINGER-INGELHEIM
04.2020 - 11.2023
  • Excelled at developing effective medical strategies for pre, peri, and post launch products in Immunology
  • Directed post-hoc analyses and real-world evidence projects by team to address key clinical and market access questions
  • Builder of diverse strong teams, servant leader, launch expert
  • Led vision for multiple therapeutic areas to direct company focus and achieve corporate goals.
  • Strategically led labeling and FDA submissions
  • Managed talent, succession planning, performance management, resource, and budget planning
  • Provided vision to Clinical, Health Economics & Outcomes Research (HEOR), and Commercial work streams
  • Introduced a three year strategic plan
  • Led strategy for investigator initiated studies that lead to label enhancement
  • Oversaw financial management, ensuring fiscal responsibility and long-term sustainability for the organization.

Senior Director and Team Leader

Regeneron
01.2016 - 02.2020
  • Set executive brand strategy
  • Managed talent, succession planning, performance management, resource, and budget planning
  • Led strategic launch planning for both global and US launches
  • Developed joint data analysis subcommittee for alliance teams to expand label
  • Transitioned from one-year strategic plans to forward looking three-year plans
  • Implemented phase IV clinical program with 20+ study concepts and contributed to design of new phase III programs
  • Set strategy for investigator-initiated grants
  • Represented medical affairs on clinical, safety, HEOR, commercial and pharmacovigilance work streams.

Director, Global Lead - Kevzara

Regeneron
08.2015 - 01.2016
  • Developed strategy for global brand, publications, and medical communication materials for global affiliates to customize
  • Developed 4 company safety registry protocols
  • Provided strategic guidance for HEOR and payer initiatives
  • Developed joint data analysis committee for alliance teams that was adopted company wide
  • Developed and executed 4 global symposia
  • Managed publication of over 12 manuscripts per year and 50 presentations per year
  • Provided strategic guidance and training to global country affiliates
  • Developed scientific communication strategy and materials.

Senior Medical Director - Men’s and Women's Health

Pfizer
06.2014 - 06.2015
  • Led US medical strategy and operations for Toviaz for US, regional, and global advisory boards
  • Developed medical content for commercial messages of Duavee and Toviaz
  • Developed strategy for independent medical grant proposals for menopause and overactive bladder
  • Coordinated strategic support for home office from field based medical teams.
  • Led field force training efforts for Duavee and Toviaz
  • US medical strategic lead for life cycle, and publications.
  • Championed continuous improvement initiatives across all areas of responsibility, leading to increased efficiencies and enhanced performance metrics.
  • Streamlined operational efficiency for the medical department by enhancing communication channels between teams.

Medical Lead Detrol LA, Toviaz and Duavee

Pfizer
01.2011 - 01.2015
  • Chaired the overactive bladder review committee, and Scientific and Commercialization support committees
  • Medical affairs lead for several ongoing clinical trial programs, and co-chaired health economics comparative effectiveness study
  • Developed, professional and consumer communications strategy
  • Led development of an elderly platform for Toviaz
  • Point of coordination for headquarters and field based medical support
  • Led medical content development for Academy of Managed Care Pharmacy (AMCP) Dossier support.

Secondment, Medical Director - Spiriva

Pfizer
09.2010 - 06.2011
  • Led Spiriva Global Advisory Board in a corporate alliance with Boehringer Ingelheim
  • Supported US and global review committees
  • Developed global Spiriva Medical Plan
  • Supported global regulatory responses.
  • Cultivated a positive work environment that fostered employee engagement, increased retention rates, and boosted overall team morale.

Director, Regional Medical and Research Specialist

Pfizer
05.2008 - 06.2011
  • Led medical and clinical support for inhaled p38K clinical program
  • Optimized clinical trial recruitment at underperforming sites
  • Supported field sales training initiatives including POA and therapeutic area training
  • Developed key opinion leader (KOL) partnerships, conducted non-biased scientific exchanges with therapeutic area KOLs
  • Led efforts to support formulary decision makers with scientific data presentations on multiple products
  • Reviewed and endorsed investigator and initiated protocols for the review committee.

Education

Clinical Immunology and Rheumatology Postdoctoral Fellowship -

University of Alabama
Birmingham, AL

Doctor of Philosophy (PhD) - Biochemistry

University of California, Los Angeles (UCLA)
Los Angeles, CA

Bachelor of Science (BS) - Chemistry

Valparaiso University
Valparaiso, IN

Skills

  • Immunology Medical Affairs
  • Rheumatology, Dermatology, and Gastroenterology Clinical Development
  • Visionary Leader
  • Life Cycle Management
  • Data Generation Strategy
  • Launches
  • Relationship Builder
  • Team Builder
  • US and Global Regulatory Submissions
  • Complex Problem-solving
  • Budget Management
  • Executive Agile Leadership
  • Scientific Communication
  • Problem and Risk Mitigation Skills
  • GCP ICH
  • FDA/EMA
  • Succession Planning

Publications

  • Effects of Sarilumab on Patient-Reported Impact of Rheumatoid Arthritis Using the Rheumatoid Arthritis Impact of Disease Scale, Gossec, L., Strand, V., Proudfoot, C., Chen, C-I., Guillonneau, S., Kimura, T., van Hoogstraten, H., Mangan, E., Reaney, M., J Rheum., 2019, 10.3899/jrheum.180904
  • Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs, Choy, E., Freemantle, N., Proudfoot, C., Chen, C-I., Pollissard, L., Kuznik, A., van Hoogstraten, H., Mangan, E., Carita, P., Huynh, T-M-T., Adv in Ther., 2019, 36, 4, 817-827

Timeline

Executive Director and Therapeutic Area Lead

BOEHRINGER-INGELHEIM
04.2020 - 11.2023

Senior Director and Team Leader

Regeneron
01.2016 - 02.2020

Director, Global Lead - Kevzara

Regeneron
08.2015 - 01.2016

Senior Medical Director - Men’s and Women's Health

Pfizer
06.2014 - 06.2015

Medical Lead Detrol LA, Toviaz and Duavee

Pfizer
01.2011 - 01.2015

Secondment, Medical Director - Spiriva

Pfizer
09.2010 - 06.2011

Director, Regional Medical and Research Specialist

Pfizer
05.2008 - 06.2011

Doctor of Philosophy (PhD) - Biochemistry

University of California, Los Angeles (UCLA)

Bachelor of Science (BS) - Chemistry

Valparaiso University

Clinical Immunology and Rheumatology Postdoctoral Fellowship -

University of Alabama
ERIN K. MANGAN PHD